ads

Thursday, November 30, 2017

Fractyl Labs raises $44 million in Series D to develop a treatment for type 2 diabetes

 Fractyl Labs, a Lexington, Massachusetts-based startup developing treatments for diabetes, has raised $44 million in Series D financing from a slew of VC firms, including GV, True Ventures, the IDO Fund, General Catalyst, Bessemer Venture Partners, Domain Associates, Mithril Capital Management, Emergent Medical Partners, L.P., and Deerfield Management Company, L.P. Fractyl has been working on… Read More


from TechCrunch http://ift.tt/2Apz9Yp
via IFTTT
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Dive into the Horrors: PvZ Battle Against the Nightmares

https://www.modcraftforge.com/minecraft/horrrs-pvz?pub=596582 If you're a fan of both PvZ (Plants vs Zombies) and Minecraft , get ready...

  • RIP to FTX?
    Image Credits: TechCrunch We had to talk about the news that rocked the crypto world this week in our  Thursday episode :  the Binance/...
  • Fintechs go shopping
    Welcome back to The Interchange, where we take a look at the hottest fintech news of the previous week. If you want to receive The Interchan...
  • Max Q: Galactic
    Hello and welcome back to Max Q! Happy Memorial Day everyone. In this issue: Astranis’ novel approach to GEO satellites Virgin Galactic’...